Intelligent Fingerprinting Scales Manufacturing Capacity

Home » Intelligent Fingerprinting Scales Manufacturing Capacity

Intelligent Fingerprinting Scales Manufacturing Capacity

Biodot Intelligent FingerprintingIntelligent Fingerprinting, the Cambridge-based company developing the world’s first portable fingerprint-based drug screening system, has scaled its manufacturing capacity ten-fold during the last year in readiness for the commercialisation of the unique drug screening system.

The first product of its kind in the world, Intelligent Fingerprinting’s portable Drug Screening System is easy-to-use, non-invasive and works in less than 10 minutes by analysing the tiny traces of sweat contained in a fingerprint.

Since moving to new 11,000 sq. ft Cambridge premises in 2015, Intelligent Fingerprinting has continued to expand its R&D and manufacturing facilities and recruit additional staff.

During the last year, the company has successfully scaled manufacturing capacity of its innovative drug test cartridges, and considerable future scale-up will be achievable without further capital investment through the addition of more production staff.

Intelligent Fingerprinting has also supported the transition towards manufacturing process automation with investments including the latest BioDot reel-to-reel production technology, automating the printing and laminating of test material for its specialist sample collection cartridges

“Our Cambridge HQ facility was designed from the outset for high throughput manufacturing, and we now have a first phase operation in place that can support production requirements following commercialisation,” commented Intelligent Fingerprinting’s CEO, Dr Jerry Walker.

“Additionally, following our recent announcement of a further £3 million of funding, we’re in a position to introduce further production and automated assembly enhancements as we scale our manufacturing to commercial volumes and reduce unit costs.”

Intelligent Fingerprinting’s in vitro diagnostic medical device development, design and manufacturing process is already certified to ISO 13485, the internationally recognised standard for medical device quality management.

With appropriate regulatory approval, the Intelligent Fingerprinting Drug Screening System can be used in many environments, any time, to support a range of applications including drug rehabilitation programmes, tackling drug use in prisons, police initiatives, coroner services, as well as establishing fitness for duty in safety critical workplaces such as the transport and construction industries.